Amanote Research

Amanote Research

    RegisterSign In

Metabolomic Discovery of Novel Urinary Galabiosylceramide Analogs as Fabry Disease Biomarkers

Journal of the American Society for Mass Spectrometry - United States
doi 10.1007/s13361-014-1060-3
Full Text
Open PDF
Abstract

Available in full text

Categories
Structural BiologySpectroscopy
Date

January 13, 2015

Authors
Michel BoutinChristiane Auray-Blais
Publisher

American Chemical Society (ACS)


Related search

Metabolomic Biomarkers: Search, Discovery and Validation

Expert Review of Molecular Diagnostics
Forensic MedicineGeneticsPathologyMolecular MedicineMolecular Biology
2007English

Urinary Biomarkers as Indicators of Renal Disease

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
1999English

Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis

Journal of Proteome Research
BiochemistryChemistry
2018English

Discovery of Novel and Long Acting GLP-1 Analogs

2015English

Urinary Biomarkers at Early ADPKD Disease Stage

PLoS ONE
Multidisciplinary
2015English

Metabolomic Analysis Identifies Potential Diagnostic Biomarkers for Aspirin-Exacerbated Respiratory Disease

Clinical and Experimental Allergy
AllergyImmunology
2016English

Discovery of Novel Biomarkers for the Development of Personalized Medicine

Translational Medicine
2012English

Fabry Disease

Revista de la Facultad de Medicina Humana
2018English

Cardiovascular Manifestations of Fabry Disease and the Novel Therapeutic Strategies

Journal of Nippon Medical School
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy